Immuron Plans Phase 3 trial for IMM-124E to Prevent Travelers’ Diarrhea

    NEXT STORY
    Myriad Genetics Announces Regulatory Approval of the BRACAnalysis® Diagnostic System in Japan for Breast Cancer Patients
    PREV STORY
    Teleflex to Present at the 31st Annual Piper Jaffray Healthcare Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Press Release: Terveystalo sells its Riga based subsidiary Ava Clinic

    On 31 July 2018, Terveystalo Group has entered into an agreement with Eugin Group, ...

    author_avatar
    NASDAQ Market News

    BeyondSpring Reports Third Quarter 2017 Operational and Financial Results

    NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI) (“BeyondSpring” or the ...

    author_avatar
    NASDAQ Market News

    Cellectar Biosciences Reports First Quarter 2017 Financial and Corporate Performance

    MADISON, Wis., May 11, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), (the “company”), ...

    author_avatar
    NASDAQ Market News